Starting Salary from £28,500 to £38,000 (Depending on experience)
Initial 3 year fixed term contract (with possibility of up to 2 year extension)
Cancer Research UK Beatson Institute in Glasgow Scotland is one of Europe's leading cancer research centres. It supports cutting-edge research into the molecular mechanisms of cancer development. The Institute provides an outstanding research environment, underpinned by state-of-the-art core services and advanced technologies with special emphasis on imaging, mass spectrometry and in vivo models.
The Vascular Proteomics group is a vibrant team focused on unravelling how the tumour microenvironment affects endothelial cell signalling and angiogenesis. We are seeking for a highly motivated and ambitious postdoctoral researcher, and we offer a unique opportunity to combine cell biology approaches to quantitative mass spectrometry proteomics to develop a new level of understanding in how tumour cells and cancer-associated fibroblasts regulate endothelial cells, with a particular focus on cell metabolism.
Successful candidates will have a PhD in a field relevant to angiogenesis and/or cell metabolism, an excellent publication record and a demonstrable capacity for independent thinking. While experience with mass spectrometry is not required, candidates should be willing to learn mass spectrometry-based approaches. An interest in using metabolic modelling is desirable.
Applications with CV and names of three referees should be sent to Dr Sara Zanivan, CR-UK Beatson Institute, Garscube Estate, Switchback Road, Bearsden, Glasgow, G61 1BD or by e-mail to
[email protected]Closing date for applications: 31 May 2015
